Cancer Research  AM No Date
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 254-258, January 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jean, D.
Right arrow Articles by Frade, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jean, D.
Right arrow Articles by Frade, R.

A Cysteine Proteinase, Which Cleaves Human C3, the Third Component of Complement, Is Involved in Tumorigenicity and Metastasis of Human Melanoma1

Didier Jean, Menashe Bar-Eli, Suyun Huang, Keping Xie, Fernando Rodrigues-Lima, Jacques Hermann and Raymond Frade2

Immunochimie des Régulations Cellulaires et des Interactions Virales, INSERM U.354, Centre INSERM, Hôpital Saint-Antoine, 184 rue du Faubourg, 75012 Paris, France [D. J., F. R-L., J. H., R. F.], and Department of Cell Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [M. B-E., S. H., K. X.]

The DM-4 human melanoma cell line, which is highly metastatic in nude mice, expresses a C3-cleaving activity that proteolyzes labeled as well as unlabeled human C3. This C3-cleaving activity is a cysteine proteinase characterized by a Mr 41,000. The p41 proteinase shares antigenis determinants with murine p39 procathepsin-L and human procathepsin-L. Preincubation of DM-4 cells with anti-p39 F(ab')2 induced up to 45% decrease in their complement resistance. Pretreatment of DM-4 cells with anti-p39 Ab strongly inhibited their tumorigenicity and significantly decreased their metastatic potential in nude mice. Thus, the p41 C3-cleaving proteinase contributes to tumorigenicity and metastasis of human melamoma DM-4 cells.

1 This work was supported by Institut National de la Sante et de la Recherche Medicale, Association pour la Recherche contre le Cancer, Comité de Paris de la Ligue Nationale Francaise contre le Cancer (to R.F.), and in part by NIH grant CA 41525 (to M. B-E.).

2 To whom requests for reprints should be addressed.

Received 10/31/95. Accepted 11/29/95.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Y. Park, Y. P. Shin, C. H. Kim, H. J. Park, Y. S. Seong, B. S. Kim, S. J. Seo, and I. H. Lee
Immune Evasion of Enterococcus faecalis by an Extracellular Gelatinase That Cleaves C3 and iC3b
J. Immunol., November 1, 2008; 181(9): 6328 - 6336.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. V. Rozanov, A. Y. Savinov, V. S. Golubkov, S. Tomlinson, and A. Y. Strongin
Interference with the complement system by tumor cell membrane type-1 matrix metalloproteinase plays a significant role in promoting metastasis in mice.
Cancer Res., June 15, 2006; 66(12): 6258 - 6263.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. V. Rozanov, A. Y. Savinov, V. S. Golubkov, T. I. Postnova, A. Remacle, S. Tomlinson, and A. Y. Strongin
Cellular Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Cleaves C3b, an Essential Component of the Complement System
J. Biol. Chem., November 5, 2004; 279(45): 46551 - 46557.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Rousselet, L. Mills, D. Jean, C. Tellez, M. Bar-Eli, and R. Frade
Inhibition of Tumorigenicity and Metastasis of Human Melanoma Cells by Anti-Cathepsin L Single Chain Variable Fragment
Cancer Res., January 1, 2004; 64(1): 146 - 151.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Junnikkala, T. S. Jokiranta, M. A. Friese, H. Jarva, P. F. Zipfel, and S. Meri
Exceptional Resistance of Human H2 Glioblastoma Cells to Complement-Mediated Killing by Expression and Utilization of Factor H and Factor H-Like Protein 1
J. Immunol., June 1, 2000; 164(11): 6075 - 6081.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.